phrykt

Artivion, Inc. (AORT): who owns it and who trades it

As of Nov 16, 2026, AORT insiders reported 50 open-market sales worth $15.6M and no purchases in the last 12 months, with 26% of the sale value made under pre-set 10b5-1 plans. The largest seller was James P Mackin (CEO), with $7.4M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Artivion

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns AORT

205 funds and institutions reported AORT shares worth $1.1B at the end of Q2 2026, about 98% of the company. The largest holder is BlackRock, Inc. with 13.7%.

Funds and institutions (13F) 98%Everyone else 2%

10 largest owners, by share of the company

BlackRock, Inc.13.7%
Nomura Asset Management International Inc.6.6%
Morgan Stanley5.3%
Juniper Investment Company, LLC4.2%
Vanguard Capital Management LLC4.1%
FMR LLC (Fidelity)4.0%
State Street Corp3.8%
Ophir Asset Management Pty Ltd3.7%
Perceptive Advisors LLC3.6%
Conestoga Capital Advisors, LLC3.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.6.67M13.75%$150M+3%
Nomura Asset Management International Inc.3.18M6.56%$71.6M+30%
Morgan Stanley2.56M5.27%$57.5M+13%
Juniper Investment Company, LLC2.02M4.16%$45.4M+70%
Vanguard Capital Management LLC2.00M4.13%$45M+3%
FMR LLC (Fidelity)1.96M4.04%$44.1M-24%
State Street Corp1.86M3.83%$41.8M+10%
Ophir Asset Management Pty Ltd1.80M3.71%$40.4M+89%
Perceptive Advisors LLC1.74M3.58%$39M+6%
Conestoga Capital Advisors, LLC1.62M3.34%$36.5M+38%
Wellington Management Group LLP1.26M2.60%$28.3M+9%
California State Teachers Retirement System1.12M2.31%$49.8M+2087%
Geode Capital Management, LLC1.11M2.30%$25M-2%
Silvercrest Asset Management Group LLC1.02M2.11%$23M+55%
Vanguard Portfolio Management LLC988,2192.04%$22.2M-5%
Dimensional Fund Advisors LP947,9411.95%$21.3M-8%
Citadel Advisors LLC827,5941.70%$18.6M+1068%
GW&K Investment Management, LLC794,4781.64%$17.9M+8%
First Eagle Investment Management, LLC693,1461.43%$15.6M+122%
Royce & Associates LP639,2821.32%$14.4M+50%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, AORT insiders reported $0 of open-market purchases and $15.6M of sales. 26% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$15.6M
50 trades, 8 people
Sales under a 10b5-1 plan
26%
Share of sale value
Latest trade
Sep 10, 2026
Filed Sep 11, 2026

Purchases and sales by month

$3.6M$3.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 10, 2026Andrew M GreenVice presidentSale11,480$24.97$287KForm 4
Sep 3, 2026Andrew M GreenVice presidentSale1,493$26.02$38.8KForm 4
Sep 2, 2026Andrew M GreenVice presidentSale6,510$27.27$178KForm 4
Aug 19, 2026James P MackinCEOSale70,000$28.96$2MForm 4
Aug 14, 2026Andrew M GreenVice presidentSale616$28.55$17.6KForm 4
Aug 14, 2026Lance A BerryCFOSale715$28.55$20.4KForm 4
Aug 12, 2026Jean F HollowayVice presidentSale977$28.49$27.8KForm 4
Jun 11, 2026Andrew M GreenVice presidentSale plan30,000$20.69$621KForm 4
Jun 11, 2026Andrew M GreenVice presidentSale plan14,001$20.71$290KForm 4
Mar 4, 2026Jean F HollowayVice presidentSale8,962$38.00$341KForm 4
Mar 3, 2026Amy HortonVice presidentSale901$37.78$34KForm 4
Mar 3, 2026Jean F HollowayVice presidentSale3,843$37.78$145KForm 4
Mar 3, 2026Marshall S. StantonVice presidentSale2,149$37.78$81.2KForm 4
Mar 3, 2026John E DavisChief Commercial OfficerSale4,573$37.78$173KForm 4
Mar 3, 2026Lance A BerryCFOSale6,316$37.78$239KForm 4
Mar 3, 2026James P MackinCEOSale17,887$37.78$676KForm 4
Mar 2, 2026Amy HortonVice presidentSale641$38.02$24.4KForm 4
Mar 2, 2026Marshall S. StantonVice presidentSale1,513$38.02$57.5KForm 4
Mar 2, 2026James P MackinCEOSale14,911$38.02$567KForm 4
Mar 2, 2026Jean F HollowayVice presidentSale2,183$38.02$83KForm 4
Mar 2, 2026Lance A BerryCFOSale5,178$38.02$197KForm 4
Mar 2, 2026John E DavisChief Commercial OfficerSale2,784$38.02$106KForm 4
Feb 24, 2026Amy HortonVice presidentSale830$35.69$29.6KForm 4
Feb 24, 2026Marshall S. StantonVice presidentSale1,259$35.69$44.9KForm 4
Feb 24, 2026Jean F HollowayVice presidentSale1,668$35.69$59.5KForm 4
Feb 24, 2026James P MackinCEOSale13,936$35.69$497KForm 4
Feb 24, 2026Lance A BerryCFOSale4,485$35.69$160KForm 4
Feb 24, 2026John E DavisChief Commercial OfficerSale2,075$35.69$74.1KForm 4
Feb 23, 2026Amy HortonVice presidentSale1,731$37.59$65.1KForm 4
Feb 23, 2026Marshall S. StantonVice presidentSale2,423$37.59$91.1KForm 4
Feb 23, 2026Jean F HollowayVice presidentSale3,079$37.59$116KForm 4
Feb 23, 2026James P MackinCEOSale20,962$37.59$788KForm 4
Feb 23, 2026Lance A BerryCFOSale4,981$37.59$187KForm 4
Feb 23, 2026John E DavisChief Commercial OfficerSale3,773$37.59$142KForm 4
Dec 15, 2025John E DavisChief Commercial OfficerSale5,000$45.11$226KForm 4
Dec 8, 2025Amy HortonVice presidentSale4,572$44.42$203KForm 4
Dec 3, 2025James P MackinCEOSale plan30,921$45.46$1.4MForm 4
Dec 3, 2025Jean F HollowayVice presidentSale2,048$45.30$92.8KForm 4
Dec 3, 2025Jean F HollowayVice presidentSale5,267$45.30$239KForm 4
Dec 2, 2025James P MackinCEOSale plan30,921$45.56$1.4MForm 4
Nov 21, 2025Marshall S. StantonVice presidentSale18,705$44.91$840KForm 4
Nov 21, 2025Marshall S. StantonVice presidentSale8,370$45.35$380KForm 4
Nov 21, 2025Marshall S. StantonVice presidentSale14,586$44.92$655KForm 4
Nov 21, 2025Marshall S. StantonVice presidentSale5,715$45.35$259KForm 4
Nov 20, 2025Marshall S. StantonVice presidentSale1,355$44.28$60KForm 4
Nov 20, 2025Marshall S. StantonVice presidentSale2,033$44.32$90.1KForm 4
Nov 20, 2025Marshall S. StantonVice presidentSale11,888$44.14$525KForm 4
Nov 18, 2025Elizabeth A HoffDirectorSale4,200$45.10$189KForm 4
Nov 17, 2025Jean F HollowayVice presidentSale plan6,394$45.17$289KForm 4
Nov 17, 2025Amy HortonVice presidentSale6,000$45.73$274KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
James P MackinPresident & CEO–$7.4MAug 19, 2026
Marshall S. StantonSVP, Clinical & MD Affair–$3.1MMar 3, 2026
Andrew M GreenSVP, Regulatory and Quality–$1.4MSep 10, 2026
Jean F HollowaySVP, General Counsel–$1.4MAug 12, 2026
Lance A BerryEVP, COO, CFO & Treasurer–$803KAug 14, 2026
John E DavisChief Commercial Officer–$720KMar 3, 2026
Amy HortonVP, Chief Accounting Officer–$631KMar 3, 2026
Elizabeth A HoffDirector–$189KNov 18, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

AORT short interest

Moderate short interest. 7.0% of AORT shares are sold short: about 1 share in 14. Over the last 12 reports the number of shares short went up 76%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.41M AORT shares were sold short, 7.0% of the shares outstanding, down 8.6% from the report before. At the average daily volume of 472,904 shares, buying them all back would take about 7.2 trading days (days to cover).

Shares short, % of all shares

6.99%May 15Oct 308.23%

Days to cover

7.2May 15Oct 308.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.41M6.99%-9%472,9047.2
Oct 15, 20263.74M7.66%+3%517,2337.2
Sep 30, 20263.62M7.43%+10%654,8745.5
Sep 15, 20263.28M6.74%+12%604,5355.4
Aug 31, 20262.93M6.00%+7%662,1704.4
Aug 14, 20262.75M5.63%+1%857,3703.2
Jul 31, 20262.71M5.55%+8%568,1484.8
Jul 15, 20262.50M5.15%+15%550,0794.5
Jun 30, 20262.18M4.49%+15%1.08M2.0
Jun 15, 20261.89M3.89%-1%810,0122.3
May 29, 20261.92M3.95%-1%679,1152.8
May 15, 20261.94M4.00%+1%1.14M1.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded AORT

Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 1 sale of AORT. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Aug 20, 2026, reported Sep 10, 2026.

Purchases 2Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Aug 20, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfSep 10, 2026Report
Jul 16, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfSep 4, 2026Report
Oct 9, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfNov 18, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Artivion company events

Artivion filed 6 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Aug 6, 2026ResultsReleased financial results. Filing
  3. May 18, 2026AnnouncementArtivion completed its previously announced acquisition of Endospan pursuant to the exercise of Artivion’s option to purchase (directly or indirectly through an affiliate) all of the outstanding securities of Endospan. Filing
  4. May 15, 2026VoteReported shareholder vote results. Filing
  5. May 7, 2026AgreementSecurities Purchase Option Agreement As previously disclosed in connection with the announcement of the Exclusive Distribution Agreement, dated September 11, 2019, between JOTEC GmbH, a wholly owned subsidiary of Artivion, Inc., a Delaware corporation formerly known as CryoLife, Inc., and Endospan… Filing
  6. Feb 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Artivion financials

Famous investors that hold AORT

4 of the 50 well-known investors we track reported holding AORT in their latest 13F filing. The largest position is Ken Griffin's, worth $26.1M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20261.14M$26.1M0.0%+38%
Israel Englander · Millennium ManagementQ3 2026559,095$12.8M0.0%New
Steve Cohen · Point72 Asset ManagementQ3 202641,532$948K0.0%New
Jim Simons · Renaissance TechnologiesQ3 202610,900$249K0.0%-84%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named AORT in the last 120 days.

FiledHolderFormStake
Oct 27, 2026BlackRock, Inc.13G/A14.7%
Oct 27, 2026BlackRock, Inc.13G/A14.7%

Questions about Artivion, Inc. (AORT) stock

Who owns the most AORT stock?

The largest reported owner of Artivion, Inc. (AORT) is BlackRock, Inc., with 13.7% of the company. In total, 205 funds and institutions reported holding AORT at the end of Q2 2026, together about 98% of the shares. See the largest owners.

Are AORT insiders buying or selling?

In the last 12 months, AORT insiders reported no open-market purchases and 50 sales worth $15.6M. The latest trade was on Sep 10, 2026. See every trade.

What is the short interest in AORT?

As of Oct 30, 2026, 3.41M AORT shares were sold short, 7.0% of the shares outstanding, down 8.6% from the report before. At the average daily volume of 472,904 shares, buying them all back would take about 7.2 trading days (days to cover). See the history.

Have members of Congress traded AORT?

Yes. 1 member of Congress reported 2 purchases and 1 sale of AORT since Nov 17, 2024. The latest was reported on Sep 10, 2026. See the trades.

Which famous investors hold AORT?

4 of the 50 well-known investors we track reported AORT in their latest 13F filing, including Ken Griffin, Israel Englander, Steve Cohen. The largest position is worth $26.1M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.